Full-Time

Medical Director

Posted on 9/12/2025

AgelessRx

AgelessRx

51-200 employees

Direct-to-consumer telehealth for longevity treatments

Compensation Overview

$275k - $315k/yr

Remote in USA

Remote

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Medical degree (MD or DO) with a valid medical license.
  • Board certification in a relevant specialty (e.g., Internal Medicine, Family Medicine).
  • Minimum of 8 years of clinical experience, including at least one leadership role.
  • Extensive knowledge of healthcare compliance, clinical operations, and regulatory standards.
  • Experience in working in the Telehealth or Digital Health Space.
  • Excellent leadership, communication, and problem-solving skills.
  • Ability to manage complex operations and lead a multidisciplinary team.
Responsibilities
  • Enhance existing clinical protocols using feedback from customers, pharmacies, the Medical team, and the Applied Science team.
  • Develop, evaluate, and implement protocols for new programs (e.g., GLP-1, SGLT2, peptides, women's HRT, NAD+, biomarker optimization).
  • Establish and manage partnerships with external organizations (e.g., DEXA, Prenuvo).
  • Contribute to product and R&D roadmaps in collaboration with the CEO and cross-functional teams.
  • Inspire, motivate, and oversee clinicians, serving as the clinical authority for escalations, audits, and protocol implementation.
  • Cultivate a growth-oriented culture among clinicians; oversee upskilling, mentoring, and performance feedback.
  • Support the VP of Clinical Operations in designing an efficient, scalable team structure.
  • Monitor compliance with legal, regulatory, and accreditation standards in collaboration with Compliance leadership.
  • Act as the collaborating physician for NPs, overseeing audits and regulatory documentation.
  • Review and revise clinical SOPs and internal documentation to ensure accuracy and consistency.
  • Analyze clinical and operational metrics (e.g., approval rate, AOV, cross-sell rate, benefit rate).
  • Partner with the Med Team Lead and VP of Clinical Ops on hiring decisions, training, onboarding, and workload distribution.
  • Monitor provider efficiency and turnaround times; ensure alignment with brand promise and patient satisfaction.
  • Develop clinician training and scripts for upselling and cross-selling longevity solutions.
  • Identify trends in patient care and collaborate with Applied Science to adjust protocols accordingly.
  • Ensure quality and consistency in patient communications and clinical decision-making across the organization.
Desired Qualifications
  • Experience/Working Knowledge of the Longevity Sciences Preferred

AgelessRx offers telehealth-based longevity care, providing access to prescription medications and therapies aimed at slowing aging and preventing age-related diseases. Its products include Metformin, Low Dose Naltrexone (LDN), NAD+ patches, and Galleri cancer screening, all available through a direct-to-consumer subscription model. Customers complete online consultations with healthcare professionals, receive prescriptions, and have treatments delivered to their homes. The company differentiates itself with science-backed treatment options, educational resources, and a portion of profits directed toward longevity research and advocacy, positioning itself to serve consumers seeking proactive health management. Its goal is to help people extend their healthspan by making preventative anti-aging care more accessible and by supporting scientific progress in longevity.

Company Size

51-200

Company Stage

N/A

Total Funding

$1

Headquarters

Ann Arbor, Michigan

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • 6,600 patients gained mental clarity; 8,300 boosted energy in 2025.
  • 5,200+ completed clinical studies on therapy efficacy.
  • 82.7% reported improvements by first check-in.

What critics are saying

  • FDA halts GLP-1 microdosing trial for unapproved anti-aging use.
  • Novo Nordisk undercuts prices, captures market in 18 months.
  • Adverse events from Rapamycin trigger lawsuits in 12 months.

What makes AgelessRx unique

  • Offers Rapamycin and microdosed GLP-1s via Stanford PhD-led trials.
  • Infinite Longevity Support targets all 9 aging hallmarks.
  • Provides 30+ diagnostics including NAD+ Nasal Spray.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

6%
Decrypt
May 2nd, 2025
Dementia Risk Tied To Biological Age In New Study

In brief The research showed that biological age can be a stronger predictor of dementia risk than chronological age.According to a February 2025 report by the National Institutes of Health, more than 6 million Americans are living with dementia.Experts say tracking biological age helps improve the understanding of health and aging, while also identifying early risks of diseases such as dementia.Decrypt’s Art, Fashion, and Entertainment Hub. Discover SCENEAging faster on the inside—even if you're still young on the outside—could raise your risk of dementia, a new study from Zhengzhou University in China found.The research showed that biological age, or how well the body is functioning, can be a stronger predictor of dementia risk than chronological age.The study, published on Wednesday in Neurology, the journal of the American Academy of Neurology, used data from the UK Biobank and tracked 280,918 people with an average age of 57 over a 14-year period.It found that faster biological aging was linked to a 14% to 15% higher risk of developing dementia.“With the rising impact of dementia around the world, identifying risk factors and implementing preventive measures is essential,” lead researcher Dr. Yacong Bo said. “While none of us can change our chronological age, we can influence our biological age through lifestyle factors such as diet and exercise.”To assess biological aging, Chinese researchers used two metrics: Klemera–Doubal Method Biological Age (KDM-BA), which uses blood test results; and PhenoAge, which draws on clinical data tied to aging and mortality.For each increase in the rate of biological aging, as measured by KDM-BA and PhenoAge, the risk of dementia rose."These brain structure changes explain some, but not all, of the association between advanced biological age and dementia," Bo continued. "These results support the hypothesis that advanced biological age may contribute to the development of dementia by causing a widespread change in brain structures."More than 6 million Americans are living with dementia, which causes about 100,000 deaths annually, according to a February 2025 report by the National Institutes of Health.While dementia has declined 13% per decade due to better education, heart health, and lifestyle, the total number of cases is rising as the population ages, increasing pressure on the healthcare system.In 2020, the number of people worldwide with dementia stood at 55 million, according to the non-profit Alzheimer’s Disease International. By 2030, the number is expected to reach 78 million, and by 2050, it is projected to reach 139 million.Age is often seen as just a number on a calendar, with chronological age referring to the number of years one has been alive

INACTIVE